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Abbreviations 
PyV    Polyomavirus 
MPyV    Mouse Polyomavirus 
HPyV    Human Polyomavirus 
dsDNA   double-stranded DNA 
vDNA    viral DNA 
UI    Uninfected 
WT    Wild Type (NG59RA) 
MEF    Murine Embryonic Fibroblast 
hpi    Hours Post Infection 
kb    kilobases 
S#    Serine amino acid residue # 
T#    Threonine amino acid residue # 
DDR    DNA Damage Repair 
 
Proteins of Interest 
TAg    Tumor Antigen (L - Large, m - middle, s - small) 
MRN    Mre11 | Rad50 | Nbs1 (protein complex) 
ATM    Ataxia Telangiectasia Mutated kinase 
PI3K    Phosphoinositide 3-kinase 
Akt    aka Protein Kinase B; serine-threonine kinase 
TOR    Target of Rapamycin; serine threonine kinase 
PRAS40   Proline-rich AKT1 substrate 1; inhibitor of mTORC1 
p70 S6 Kinase   Ribosomal protein S6 kinase beta-1; serine threonine kinase 
p27    Cyclin-dependent kinase inhibitor 1B (p27Kip1) 
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I. Abstract 
Greater than 80% of adults are infected by one or more human polyomaviruses (HPyVs) (Kean 
and Garcea 2009).  Polyomaviruses (PyVs) typically cause an asymptomatic infection within their 
hosts (birds, rodents, primates); however, under immunocompromised conditions PyV replication 
can cause a variety of illnesses (Fanning E. et. al. 2009).  PPyV efficiently replicate by disrupting host 
cell signaling pathways.  Disruption of the cell cycle is implicated in nearly all tumor formation.  
Studies of cellular transformation by primate PyV, SV40, and mouse polyomavirus (MPyV) have led 
to numerous findings concerning tumor suppressor proteins and cell cycle regulation pathways (Das 
D. and Imperiale 2009, Dahl et. al. 2005).  Successful PyV replication can occur when the cell is 
promoted to S phase and kept there by the cell’s own regulatory system.  Expression of PyV T 
Antigen (TAg) early genes modifies signaling pathways and cell cycle checkpoints to the virus’ 
advantage.  Expected modifications include inhibiting checkpoint proteins between G1 and S phases 
as well as promoting kinases with downstream signaling effects that result in progression to S phase 
(Fanning et. al. 2009).  Unlike in SV40 (Zhao et. al. 2008), the MRN complex has not been found to 
decrease during infection with MPyV.  Other cell cycle signaling pathways are dysregulated during 
MPyV infection through phosphorylation events.  MPyV TAg splice variants each play independent 
yet complementary roles in promoting viral replication.  The presence of mTAg alone has been 
shown to alter the downstream effects of Akt and TOR pathways in order to initiate cell 
proliferation and push the cell into S phase, aiding viral replication (Summers et. al. 1998 and Meili 
et. al. 1998).  Presented here is evidence of mTAg activating Akt and TOR in the context of a full 
MPyV infection.  Furthermore, p70 S6 Kinase, a downstream effector of the Akt/TOR pathways 
and a motivator of translation, was also observed to increase levels of activation during MPyV 
infection.  The cell cycle checkpoint regulator p27 was found to be suppressed during MPyV 
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infection, allowing the cell to progress to the S phase.  MPyV mTAg is necessary, in tandem with 
LTAg to alter cell cycle signaling that allows vDNA replication to proceed efficiently. 
II. Background 
Polyomaviridae   
Polyoma describes a family of viruses that were originally named based on the observation that 
they can cause many (“poly”) tumors (“oma”) after injection into newborn mice.  PyVs are non-
enveloped, ~5-6 kb, double-stranded DNA (dsDNA) viruses.  The genome encodes three early 
expressed genes that produce Large (L), middle (m), and small (s) TAgs via alternative splicing and 
three late expressed genes VP1, 2, and 3 (Fig. 1).  VP1, 2, and 3 are coat proteins that encapsidate 
the viral genome (Fluck and Schaffhausen 2009).  Cell entry is facilitated by coat proteins binding to 
specific extracellular ganglioside receptors. Endocytosis delivers the viral capsids to the ER where 
they are partially disassembled and then redirected to the nucleus to begin replication of the viral 
genome (Fanning et. al. 2009).    
 
 
 
Figure 1: Mouse Polyomavirus Genome.  
Depiction of the MPyV genome showing 
early genes for TAg splice variants L/m/s 
TAg and late genes VP1/2/3.  (Adapted 
from Fluck and Schaffhausen 2009) 
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Polyomavirus T Antigens 
Early expression of viral TAgs is critical in driving vDNA replication.  Each T antigen has a 
specific role in MPyV DNA replication, translation, and nascent capsid assembly.  Large T antigen 
(LTAg) is a ~100 kDa nuclear protein with helicase activity that aids in the replication and 
transcription of viral DNA in addition to interacting with a wide variety of cell signaling pathways 
that mediate cell growth, death, and an inflammatory response.  LTAg is absolutely essential for a 
productive PyV infection, beginning with stalling the cell in S phase and directly hijacking host 
replication machinery (An et. al. 2012).  MPyV middle Tag (mTAg) is ~56 kDa, membrane-bound 
and affects numerous cell signaling pathways, viral transcription, and viral translation.  In most other 
PyV species, only LTAg and sTAg transcripts are expressed.  MPyV mTAg functions similarly to 
SV40 sTAg, and this gene, known as the cell transforming factor, is highly conserved in all PyVs 
known to date (Dilworth 2002).  MPyV small Tag (sTAg), ~22 kDa localizes to the cytoplasm and is 
known to inhibit phosphatase 2 A (PP2A).  PP2A is a tumor suppressor, and dysregulation of PP2A 
can result in disrupted cell signaling and transformation of the cell (Hwang et. al. 2013).  Note that 
while each MPyV splice variant specializes in a particular aspect of infection, each likely enhances 
the work of the others, and together, L/m/sTAgs collaborate to drive the cell toward optimal 
conditions for vDNA replication and new virion assembly. 
 
Mutant MPyVs 
In order to more fully appreciate the varied roles that the TAg splice variants play during MPyV 
infection, mutant viruses deficient in mTAg and sTAg were used and compared to the wild type 
(WT) virus (NG59RA).  Mutant MPyVs described in the following work include NG59 and 808A 
(Fig 2).  The NG59 mutant was selected in a chemical mutagenesis screen.  NG59 has a codon 
insertion (ATA) immediately followed by a nucleotide change (GA).  This results in an extra 
Fluck and Schaffhausen 
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isoleucine and an amino acid change of Aspartate (negatively charged) to Asparagine (polar, 
uncharged) in the mTAg region (Carmichael and Benjamin 1979).  These mutations reduce the 
normal functions of mTAg and sTAg.  MPyV mutant 808A was created by site directed mutagenesis 
resulting in a deletion of the mTAg splice acceptor site.  The deletion completely abrogates 
expression of mTAg while still allowing for normal LTAg and sTAg expression.  The WT virus used 
as a control was rescued from the NG59 mutant and is termed NG59RA, but will be referred to 
simply as RA henceforth.  RA expresses fully functioning LTAg, mTAg, and sTAg (Benjamin 1970, 
Benjamin 1982, Garcea et. al. 1989). 
Immunofluorescence of infected cells shows co-localization of MPyV DNA and the proteins of 
the MRN complex in WT and mutant MPyV infections (Erickson et. al. 2012).  However, MPyV 
mutant strains are impaired in their ability to replicate viral DNA and produce infectious viral 
progeny (Dawei 2009).  Observations of mutant infections show that viral replication centers are 
smaller in cells infected with mTAg and sTAg deficient strains.  Additionally, virus mutants unable 
to express mTAg and sTAg produce new virions at lower levels than WT.  These data suggest that 
mTag and sTag may play a role in viral replication by regulating the MRN complex or other cell 
signaling activity.  My work investigates the interaction of MPyV TAg with host cell signaling 
pathways and suggests how the absence or presence of mTAg and sTAg may affect such 
interactions.    
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Figure 2: Diagram of Mutant TAgs.  NG59RA, NG59, and 808A MPyV TAg genes are depicted.  
MPyV RA expresses all three splice variants, LTAg, TAg, and sTAg.  MPyV mutant NG59 expresses 
LTAg as normal.  As indicated, the MPyV mutant NG59 has a mutation in mTAg which causes both 
mTAg and sTAg to have reduced functionality when expressed.  MPyV mutant 808A also expresses a 
normal LTAg transcript as well as a normal sTAg transcript.  The splice acceptor site for mTAg is deleted 
in mutant 808A, so no mTAg transcript is expressed. 
 
Figure 3: Cell Cycle.  Diagram illustrating 
phases of the cell cycle: G1, S, G2, M. 
Progression between phases is regulated by 
checkpoint proteins and kinase activity. 
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Cell Cycle Signaling 
Eukaryotic cells follow a conserved cell cycle that consists of growth (G1, G2), DNA 
replication and synthesis (S), and division (M – mitosis) phases (Fig. 3).  Transition between phases, 
particularly G1S and G2M, is regulated by a variety of pathways and checkpoints.  These 
regulatory pathways are largely activated or inhibited by kinases.  The presence or absence of a 
phosphate group on proteins determines their activation state, interaction with other proteins, and 
ability to regulate downstream effectors, all of which are crucial in directing the cell cycle.  It is 
common for transmembrane receptor proteins, often kinases, to relay signals from extracellular 
ligands to intracellular proteins that regulate cell cycle pathways (Diaz-Moralli et. al. 2013).  PI3K, a 
kinase that interacts with intracellular domains of membrane proteins, phosphorylates Akt initiating 
Figure 4: Cell Proliferation Signaling.  Activation of the PI3K/Akt pathway leads to a myriad of downstream effects.  Of interest in the 
context of this discussion is the promotion of cell growth and proliferation via translation activity through TOR and P70 S6 Kinase. 
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a series of downstream effects (Fig. 4).  Akt (also known as Protein Kinase B) is a protein with 
Serine-Threonine kinase activity that directly promotes glucose metabolism, apoptosis, cell growth, 
transcription, and cell migration.  Activation of Akt can lead to direct activation of the TOR 
complex.  The TOR complex is negatively regulated by PRAS40.  Akt has been shown to directly 
phosphorylate PRAS40 T246, releasing it from the TOR complex and allowing TOR to be activated.  
Additionally, Akt has been shown to phosphorylate and activate the TOR complex.  Upon TOR 
activation, activities such as amino acid biosynthesis, translation, and cell proliferation are promoted, 
driving the cell towards the S phase.  Additionally, both Akt and TOR activate p70 S6 Kinase which 
is known to play a role in targeting translation machinery activation for cell proliferation (Wiza et. al. 
2012).  p27, a cell cycle regulator, controls progression of the cell cycle at G1.  Upon 
phosphorylation, p27 suspension of the cell cycle is lifted and the cell progresses to S phase for 
DNA replication (Fujita et. al. 2003).  Progression of the cell cycle into S phase is regulated by these 
proteins (among many others) an contributes to activation of transcriptional and translational 
machinery. 
 
Viral Disruption of Normal Cell Cycle Signaling Pathways 
Viruses typically either evade cell cycle regulation checkpoints or commandeer them to give 
viral DNA (vDNA) replication priority.  PyVs actively disrupt normal cell cycle signaling in order to 
promote efficient vDNA replication by encouraging the cell to move into S phase.  PyV mediated 
disruption occurs via activation or inhibition of key signaling molecules that affect various regulatory 
mechanisms.  LTAg directly binds Rb, thereby preventing Rb from halting the cell cycle at G1 
(Cheng 2009).  MPyV mTAg serves as a membrane bound platform for various cellular factors 
(PP2A, c-Src, etc.) to assemble and modify signaling pathways.  These modifications occur via 
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phosphorylation by kinases and can contribute to tumor formation by altering cell cycle signaling 
(Das and Imperiale 2009, Dahl et. al. 2005).   
 
Nuclear Cell Signaling during MPyV Infection 
During events of stress or damage, the cell cycle is paused to allow time for specific repair 
machinery to assemble and respond to the damage.  This halt of the cycle prevents damaged DNA 
from being replicated.  Repair machinery is recruited by specialized DDR pathways which are 
activated as soon as damage is detected.   ATM kinase (an important regulator of the cell cycle) is 
activated in the presence of double-stranded breaks (ionizing radiation) and halts cell cycle 
progression (Fig. 5).  The MRN complex (Mre11, Rad50, Nbs1) is required for the recruitment of 
ATM kinase, leading to downstream signaling of other DDR proteins.  ATM kinase induces a cell-
cycle halt at G1S, intra-S, and G2M in order for repair to occur (Kurz and Miller 2004).    
PyV LTAg expression results in activation of DDR pathways, specifically the ATM pathway.  
In the case of PyV infection, DDR proteins 
are utilized to support viral 
replication.   During PyV infection, proteins 
of the MRN complex are localized to sites of 
vDNA replication and ATM kinase is 
activated (Dahl et. al. 2005, Zhao et. al. 
2008).  Data not depicted here shows that 
Figure 5: Double-strand DNA Break Repair The 
MRN complex associates with damaged DNA at the 
site of the break.  This association recruits ATM 
Kinase to the site which results in bringing repair 
machinery in to repair damage and suspending the 
cell cycle until damage is repaired. 
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the MRN complex is chromatin associated; however, the roles of viral proteins in recruitment of the 
MRN complex and other DDR proteins are poorly characterized.  Work from Zhao et. al. 2008 
describes a proteasome dependent degradation of MRN, specifically Rad50 and Nbs1, as primate 
PyV SV40 infection proceeds.  The authors found that ATM and MRN co-localized with viral 
replication centers and suggested that ATM was recruited by TAg.  They propose that ATM serves 
as the “master regulator for TAg-directed host reprogramming” due to their published evidence that 
it directs the MRN complex for degradation.  Evidence for TAg interaction with ATM signaling 
once again implies that the virus takes command and reorganizes normal cell signaling processes in 
order to promote efficient vDNA replication. 
 
III. Aims 
Question: How does the presence of MPyV TAg influence DDR, Cell Cycle, and Cell 
Signaling pathways? 
Aim I:   Do MRN complex protein steady state levels decrease in response to MPyV infection as is 
reported in SV40 PyV?  
Aim II: How does the presence or absence of TAg splice variants mTAg and sTAg in MPyV 
mutants affect phosphorylation of other cell signaling proteins? 
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IV. Materials and Methods 
        Tissue Culture:  
C57 Mouse Embryonic Fibroblast C57 cells were grown in Dulbecco’s Modified Eagle’s 
Medium (DMEM, Sigma) with 10% Fetal Bovine Serum (FBS), 1% Penicillin-Streptomycin Solution 
(P/S), and 60uM β-Mercaptoethanol (BME).  Cells were maintained in an incubator at 5% CO2, 
37⁰C. 
        Infection 
16-24 hours prior to infection, cells were treated with starve media (0.5% 
FBS/DMEM/P/S/BME). Cells were infected with NG59RA (RA), NG59 and 808A viruses (kindly 
provided by Tom Benjamin) in Adsorption Serum (HBSS / 0.5% BCS / 10 mM Hepes pH 5.6).  
After a 1.5 hour infection, the cells were placed in starve media for 24 or 26-28 hours until lysis or 
fixing respectively.  Multiplicity of Infection (MOI) are the standard units describing the number of 
virus particles infecting each cell and is calculated from the titer of the virus stock and dilution 
required for a specific level of infection.  Cells are infected with the same MOI for each experiment. 
 Viral Infection Level Quantification Assay:  
Using a 96-well plate, 2000 cells/well were plated and infected as described above, though 
serial dilutions of virus were used for infection.  At 26-28 hpi, cells were fixed with 4% 
paraformaldehyde in PBS and permeabilized with 0.5% TritonX100 in PBS.  After blocking in 5% 
BCS/PBS serum for one hour to overnight, the cells were stained with primary antibodies TAg and 
VP1 for 45 minutes at 37⁰C.  Following the primary antibodies, Rat AlexaFluor 546 and Rabbit 
AlexaFluor 488 secondary antibodies were applied to each well for 45 minutes at 37⁰C.  Afterwards, 
5 ug/ml Hoescht dye was added to stain the nuclei for 15 minutes.  The plate was imaged on the 
Molecular Devices ImageXpress Micro XL microscope using MetaXpress software with the help of 
Katie Heiser.  Cell counts and percent infections were calculated through analysis with ImageJ.   
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 Cell Lysis:  
Cells were scraped into starve media and centrifuged for 10 minutes at 1500 rpm.  Pellets 
were then washed with 1 ml ice cold PBS and then centrifuged for 5 minutes at 10,000 rpm.  Pellets 
were lysed with 200 ul 2X SDS Lysis Buffer (25mM Tris, pH 6.8 / 1% SDS / 6.25 mM EDTA) on 
ice for 15 minutes.  Each sample was briefly sonicated to shear DNA. 
For the p-Akt/Akt immunoblots, Lysis Buffer 6 (LB6) from R&D Systems Human 
Phospho-Kinase Array Kit (ARY003B) was used on cells at 24 hpi.  Lysis procedure was the same.   
 Previous work was done to optimize the lysis buffer.  Lysis buffers tested include: various 
SDS based solutions, TEB (PBS / 0.25% TritonX100, with protease inhibitors for cytoplasmic 
proteins), 0.2N HCl (nuclear proteins), RIPA (50 mM Tris pH 7-8 / 150 mM NaCl, 0.1% SDS / 
0.5% sodium deoxycholate / 1% TritonX100), and CSK (10 mM PIPES pH 6.8 / 100 mM NaCl / 
300 mM sucrose / 3 mM MgCl2 / 1 mM EGTA / 0.5% TritonX100, with protease and phosphatase 
inhibitors – isolates soluble and insoluble fractions).  TEB and CSK buffers confirmed that MRN 
was chromatin associated.  The 2X SDS Lysis Buffer described was determined to produce the 
cleanest samples for immunoblotting and is the buffer used for the MRN and TAg protein blots 
shown here.   
 SDS-PAGE and Immunoblotting:  
After extraction, total protein concentration of each sample was determined by BioRad DC Protein 
Assay (Thermo Scientific Pierce BCA Protein Assay for lysates obtained from LB6).  Samples were 
prepared by dilution in 4x SDS Sample Buffer (1 M Tris, pH 6.8 / 2% SDS / 12.5 mM EDTA / 
40% Glycerol / 600 mM BME / 0.02% Bromophenol Blue) and boiled.  After, samples were loaded 
on 8% PAGE gels at 50 ug/ul (15 ug/ul for LB6).  Proteins were transferred to PVDF membranes 
and stained with the indicated antibodies.  Prior to antibody incubation, membranes were blocked in 
5% milk with 1 mM Na3VO4 and 25 mM NaF phosphatase inhibitors for 30 minutes to overnight.  
MPyV TAgs and Cell Cycle Signaling   Nicholas 15 
 
Antibodies (Table 1) were detected with the 
enhanced chemiluminescence kit from Thermo 
Scientific and imaged or exposed to film.  
Observed bands were quantified by calculating 
the integrated density and normalizing to a 
tubulin loading control. 
R&D Systems Proteome Profiler Human Phospho-Kinase Array Kit   
In order to identify the phosphorylation state of common cell cycle signaling kinases, a 
phospho-kinase array produced by R&D Systems was used.  Sample lysate was applied to the 
provided membranes which contained antibodies specific for a variety of target proteins.  Next, a 
second solution of antibodies were added that are specific for phosphorylation sites on the target 
proteins.  A Biotin-Streptavidin-HRP solution was added, resulting in a chemiluminescent reaction 
from which the membranes can be imaged or developed.  Much like an immunoblot, the resulting 
dots can be quantified by calculating the integrated density of each and normalizing to a PBS spot. 
Sixteen 10 cm2 dishes were plated with 4.8 x 106 cells/dish, two 96-well plates were plated with 
2000 cells/well, and sixteen glass coverslips for confocal microscopy were plated with 1.6 x 105 
cells/coverslip.  All cells were infected as described above with an MOI=30.  The specific dilutions 
used were calculated and normalized based on varying cell numbers and volume of liquid in a dish.    
These calculations made sure the same number of virus particles had access to each cell – ensuring 
sufficient levels of infection and subsequent TAg expression.  Eight of the 10 cm2 dishes were used 
for the array, while the remaining eight dishes were used to collect lysate with the Array Kit lysis 
buffer 6 for immunoblot analysis.  The 96 well plates were used to confirm normalized levels of 
infection for the Array.  At 24 hpi, the kit was used as directed, extra lysate was collected for 
immunoblots, and the 96-well plates were prepared for imaging as described previously. 
Table 1: Antibodies.  List of antibodies used in 
experiments along with their source. 
Antigen Antibody Source 
TAg  Brian Schaffhausen (PN116) 
Mre11 GeneTex (GTX118741) 
Rad50 GeneTex (GTX119731) 
Nbs1 Novus (NBP1-06609) 
Tubulin Novus (NB120-11304) clone B-5-1-2 
pAkt Cell Signaling #4058 
Akt Cell Signaling #9272 
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V. Results 
Viral Protein Expression during MPyV NG59RA Infection at 26 hpi Confocal Microscopy 
At 26 hpi with MPyV RA, the cell has begun expressing both early and late genes (Fig. 6).  
Expression indicates that the virus has successfully trafficked to the nucleus and was able to produce 
TAgs.  TAg expression then likely altered cell cycle regulation to promote S phase, allowing viral 
control of replication machinery.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Expression of TAgs and VP1 during 
infection of RA at 26 hpi.  1.6x105 C57 cells per glass 
coverslip were infected with RA MOI 30 as described in 
the methods.  At 26 hpi the cells were fixed, 
permeabilized, and stained for TAg and VP1.  Images were 
taken on a Nikon A1R Confocal and TIRF microscope 
with the help of Sam O’Hara and analyzed using ImageJ. 
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MRN protein levels are not decreased during viral infection 
  Immunostaining for MRN proteins in samples infected with MPyVs RA, NG59, and 808A 
does not show a decrease in protein abundance as compared to an UI sample (Fig. 7 A, B, C, D, E).  
All samples were quantified and normalized to the protein loading control tubulin.  The data shown 
are representative of 23 repeated experiments using various extraction buffers and extraction times 
post infection for optimization.  All MRN protein immunoblot data previously compiled from the 
differing extraction methods concur that there is not a decrease in MRN proteins during infection 
by WT or mutant viruses.  The change in MRN protein abundance pictured is an insignificant 
increase (Fig. 7 C, D, E).  Immunostaining for TAg confirms that the correct virus was used for 
each sample and the UI sample was not contaminated (Fig. 7 B, F). 
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Determination of Viral Titers via a Percent Infection Assay of RA, NG59, and 808A MPyVs 
In order to understand the effects of viral protein expression on cell signaling, we attempted to 
infect cells with equal amounts of virus.  The viral titer for MPyV RA was known to be 1.8 x 108 
PFU/ml.  The titers of the mutant viruses were not previously known.  Earlier work attempted to 
calculate the titers of MPyV mutants using viral plaque assays.  However, the viral strains used in 
this study are known as ‘small plaque’ viruses and were not found to create any observable plaques 
by numerous staining method protocols.  Hemagglutination (HA) assays were also performed with 
the MPyV strains.  The drawback of this assay is that by binding to the viral capsid proteins, the HA 
assay only measures viral particles in a sample and does not report infectious particles (those with 
productive genomes).  Estimations of viral particles/ml using this method may be 7-8 orders of 
0
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Figure 7: Analysis of MRN expression in response to infection.  C57 MEFs were infected with MPyVs RA, NG59, and 808A (with 
an UI mock-infected control) for 1.5 hours.  Whole cell lysates were harvested with 2X SDS Lysis Buffer at 24 hpi.  A: Immunoblots of Nbs1 
and Mre11 show no decrease in protein abundance during infection.  B: Immunoblot of Rad50 shows no decrease in protein abundance 
during infection.   Immunoblot of TAg shows LTAg expression in infected samples.  Mutants NG59 and 808A show lower levels of LTAg 
than WT.  As expected, only RA and NG59 infected samples show bands corresponding to mTAg.  C, D, E:  Quantification of Mre11, Rad50, 
and Nbs1 immunoblots normalized to their respective tubulin loading control followed by normalization to the UI sample confirms that there 
is not a decrease in protein accumulation during infection.  F. Quantification of LTAg and mTAg immunoblots normalized to a tubulin 
control shows lower levels of LTAg in mutant viruses. 
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magnitude greater than the number of productive virions/ml in the stocks of each MPyV strain, 
indicating a large number of empty/non-productive virion capsids.    
To overcome the issues that arise with other methods, Katie Heiser developed a new assay that 
can be used to measure the levels of infection between WT and mutant MPyV strains.  With 
standard curves of infection levels, these values could be used to calculate relative viral titers for the 
mutant viruses. The levels of infection between WT and mutant MPyVs were compared via an 
immunofluorescence staining analysis  of TAg and VP1 (Fig. 8).  Using serial dilutions, a standard 
curve was generated for each virus that compared the percent of infection to the dilution of virus 
used.  TAg expression was used as a marker of an infected cell and determined the calculations.  
Using the curve for each MPyV strain, the dilution was identified at which there was a 50% level of 
infection (# infected cells/total number of cells as quantified by expression of viral TAg).  The 
dilution was then used to calculate for MPyV RA to comparatively calculate the viral titers of each 
mutant.  Mutant NG59 has a titer of 1.123 x 107 PFU/ml and mutant 808A has a titer of 2.36 x 107 
PFU/ml.  With these titers, the same MOI can be used to infect cells which controls for levels of 
infection between the viruses.  Images shown are the levels of infection achieved from the dilutions 
of virus used in the phospho-kinase array at an MOI equal to 30. 
 
 
Figure 8: Levels of Infection by WT MPyV and MPyV mutants NG59 and 808A for Array Data.  Each MPyV, RA, NG59, and 808A was 
diluted to an MOI of 30 for infection.  At 26 hpi the cells were fixed, permeabilized, and stained for TAg (AlexaFluor 546) and VP1 (AlexaFluor 448).  
Nuclei are depicted in blue, TAg in red, and VP1 in green.  Calculated levels of infection based on TAg expression averaged across 6 wells per virus 
were found to be: MPyV RA: 69.5%, mutant MPyV NG59: 79.6%, and mutant 808A MPyV: 49.3%.  This and prior work has indicated that virus 
mutant 808A takes longer to infect and express viral proteins than MPyV RA or mutant NG59 and may not be able to reach the same peak levels of 
infection. 
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Akt S473 phosphorylation is induced during NG59RA infection 
 Cell proliferation signaling via the Akt pathway can result in transition to S phase and 
promotion of vDNA replication.  MPyV RA infection significantly increases phosphorylation of Akt 
(p=0.022) (Fig. 9).   This evidence suggests an effect between mTAg and Akt.  The increase in 
phosphorylation of Akt by 
mutant MPyV NG59 is also 
significant (p=0.0058) (Fig. 9).  
This may suggest that mutant 
MPyV NG59 mTAg has partial 
functionality, allowing it to 
participate in Akt activation.  
There is no difference in 
activation of Akt by mutant 
MPyV 808A (Fig. 9) which conveys that mTAg 
is essential for the activation of Akt.  
  
 
 
 
 
 
 
 
 
 
A 
Figure 9: Analysis of p-Akt levels during PyV 
infection.  A:  Phospho-kinase array data displaying levels of 
phosphorylation on S473 of Akt during viral infection.  B: 
Immunoblot data from the same lysate as the array experiment 
confirms that phosphorylation of Akt increased significantly during 
RA infection as compared to UI or mutant viruses.  The antibody 
used for immunostaining has specificity for the same S473 site as 
the array antibody.  C: Quantification of immunoblot from B as 
normalized to total Akt demonstrates the same trend as in A.  
 
Akt S473 Two-Tailed p Value
UI & RA 0.0058
UI & 59 0.0058
UI & 808A 0.5497
RA & 59 0.0259
RA & 808A 0.0219
59 & 808A 0.0397
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TOR and PRAS40 phosphorylation is induced during MPyV infection 
 During infection, PRAS40 inactivation and subsequent TOR activation occurs at the highest 
levels in MPyV WT virus, though all viruses indicate >2x more phosphorylation of PRAS40 than 
uninfected cells (Fig. 10).  The increased phosphorylation of PRAS40 by all viruses may indicate that 
LTAg plays some role (either directly or indirectly) in directing phosphorylation of PRAS40 T246 
than does mTAg or sTAg.   However, the difference in phosphorylation of RA and both mutant 
viruses of ~35.7% is statistically significant (Fig. 10), implying that mTAg also directly targets 
PRAS40.  TOR activation in the presence of mTAg shows a similar pattern as does the removal of 
its inhibitor, PRAS40, with ~33.3% greater activation in the presence of MPyV RA than the two 
mutant viruses (Fig. 10).  
 
 
 
 
 
Figure 10: Downstream effectors TOR S2448 and PRAS40 T246 phosphorylated by Akt from phospho-kinase 
array data.  PRAS40 T246 phosphorylation increases due to infection by MPyVs RA, NG59, and 808A.  The result is 
activation of the TOR complex due to relief from the inhibitory effects of PRAS40.  The most significant increase occurs 
in MPyV RA, suggesting that mTAg mediates this phosphorylation event; however, the slight increase in phosphorylation 
by both mutant viruses may indicate that LTAg has either a direct or indirect role in activating TOR through 
PRAS40.   TOR S2448 phosphorylation occurs in a nearly identical pattern as does PRAS40.     
 
TOR S2448 Two-Tailed p Value
UI & RA 0.0876
UI & 59 0.1915
UI & 808A 0.2391
RA & 59 0.0126
RA & 808A 0.1239
59 & 808A 0.5171
PRAS40 T246 Two-Tailed p Value
UI & RA 0.0548
UI & 59 0.1093
UI & 808A 0.1252
RA & 59 0.0003
RA & 808A 0.0470
59 & 808A 0.6501
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P70 S6 Kinase phosphorylation is induced during infection with NG59RA, NG59, and 808A 
viruses 
MPyV RA induces ~69.2% more phosphorylation of p70 S6 Kinase when compared to an 
UI sample (Fig 11).  The mutant MPyV NG59 lysate induces ~33.3-45.5% additional 
phosphorylation at the three sites (T389, T421, S424) than the mutant MPyV 808A sample, but both 
mutants phosphorylate this protein at lower levels than does WT MPyV (Fig. 11).  This data may 
indicate that the NG59 mutant virus has some partial mTAg functionality and contributes to 
phosphorylation of p70 S6 Kinase T389.  It is also possible that expression of LTAg is either 
directly or indirectly affecting phosphorylation of these sites. 
  
 
 
p70 S6 Kinase T389 Two-Tailed p Value
UI & RA 0.0069
UI & 59 0.0448
UI & 808A 0.1815
RA & 59 0.1837
RA & 808A 0.0193
59 & 808A 0.1028
p70 S6 Kinase T421, S424 Two-Tailed p Value
UI & RA 0.0741
UI & 59 0.1067
UI & 808A 0.0297
RA & 59 0.1019
RA & 808A 0.0986
59 & 808A 0.1847
Figure 11: p70 S6 Kinase activation via phosphorylation in response to PyV infection.  
Phosphorylation of p70 S6 Kinase T389, T421, and T424 residues increases due to infection by MPyV.  WT 
MPyV has the greatest effect in promoting phosphorylation, indicating the importance of functional mTAg. 
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A lack of phosphorylation of p27 is observed during infection with NG59RA, NG59, and 
808A viruses 
 There is a 5.4-fold reduction in phosphorylation on the T198 residue of p27 during infection 
of MPyV RA (Fig. 12).  The mutant MPyVs NG59 and 808A also show reductions in 
phosphorylation between one and two-fold (Fig. 12).  These results suggest that the presence of 
MPyV encourages the cell cycle to progress to S phase by interacting either directly or indirectly with 
p27.  mTAg has a pronounced effect on this outcome, however there may be influence from LTAg 
either through direct or indirect mechanisms. 
 
 
 
 
 
 
 
 
Figure 12: p27 phosphorylation is reduced during MPyV infection.   The data shown here indicate that phosphorylation 
of p27 is reduced during MPyV infection.  The presence of mTAg seems to significantly affect this outcome; however, 
because the mutant MPyVs also show reduced phosphorylation, a direct or indirect role for LTAg should also be considered.   
 
p27 T198 Two-Tailed p Value
UI & RA 0.2220
UI & 59 0.1464
UI & 808A 0.1649
RA & 59 0.3142
RA & 808A 0.3729
59 & 808A 0.3356
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VI. Discussion 
 Previous work has indirectly implicated MPyV mTAg in affecting major cell cycle signaling 
pathways, yet these studies were done either by transfection of mTAg plasmids or through the use 
of primate PyV SV40.  Here I show cell signaling dysregulation in accordance with previously 
published work during normal infection conditions by MPyV.   
PyV initiated DDR via TAg expression has been previously established as a hallmark of 
infection that keeps the cell in S phase to promote viral replication (An et. al. 2012).  Contrary to the 
studies of SV40 TAgs by Zhao et. al. 2008, we found no evidence that supports a decrease in 
abundance of MRN during MPyV infection.  SV40 LTAg has been shown to bind Nbs1, yet a 
similar interaction in MPyV is unclear, and does not target the complex for degradation (Wu et. al. 
2004).  Mre11 and vDNA have been shown to co-localize during MPyV infection, suggesting that 
the virus does in some way modify the ATM DDR pathway (Erickson et. al. 2012).  Activation of 
ATM and a subsequent pause in the cell cycle is advantageous for PyV because this prevents the cell 
from moving out of S phase.  The activation states of other ATM pathway proteins were considered 
in the context of infection.  Antibodies for p-ATM, p-Nbs1, and γH2AX were used in 
immunostaining but did not give results in our MEF system.  Furthermore, p-ATM is a large protein 
of 370+ kDa and difficult to resolve on a gel.  Commercial antibodies for other phosphorylated 
MRN and DDR proteins are not currently available for use in MEFs. 
Under the premise that MPyV most efficiently replicates when the cell is in S phase, we 
began preliminary work into understanding how the virus, specifically TAg splice variants, might 
affect the activation states of proteins involved in cell cycle signaling and cell proliferation pathways.  
Such interactions with cell cycle regulators could potentially lead to cellular transformation and 
tumor formation.  The phospho-kinase array developed by R&D Systems provided an efficient tool 
for such a study.   
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Investigations by Summers et. al. 1998 and Meili et. al. 1998 both established that MPyV 
mTAg is involved in the activation of Akt and p70 S6 Kinase, dependent on the simultaneous 
stimulation of PI3K.  Summers et. al. describes how mTAg can facilitate these interactions by 
comparing the intracellular domain of mTAg to that of cytoplasmic tails of activated growth factor 
receptors which interact with a plethora of signaling molecules to regulate numerous downstream 
effects.  The phospho-kinase array establishes a nineteen-fold increase in phosphorylation of Akt 
S473 and a greater than three-fold increase in phosphorylation of p70 S6 Kinase T389, T421, and 
T424 during MPyV RA infection as compared to UI cells.  The mutants analyzed in this array 
contained either functionally handicapped mTAg (NG59) or were completely missing mTAg (808A), 
and thus did not show the same levels of activation as did WT virus (RA).  The previously published 
studies looked at the ability of mTAg mutants to bind p85 and thus activate PI3K through the use 
of transfected mTAg mutants rather than under the conditions of normal infection (i.e. 
simultaneous expression of LTAg) (Summers et. al. 1998 and Meili et. al. 1998).  It is promising that 
in the context of a full infection where LTAg is expressed, we have data to support mTAg as the 
primary contributor to Akt and p70 S6 Kinase activation.   
Signaling by TOR and p70 S6 Kinase promotes cell proliferation and translation initiation 
which is necessary for the virus to produce high quantities of viral packaging proteins VP1/2/3.  
p70 S6 Kinase is a direct target of the activated TOR complex.  However, TOR cannot be activated 
until inhibitor molecule PRAS40 dissociates.  Activated Akt serves as the kinase that facilitates 
transfer of a phosphate group to PRAS40 T246 which removes its inhibitory effect on TOR.  
Furthermore, TOR S2448 and p70 S6 Kinase have been found to phosphorylate each other in order 
to respond to contrary cellular signals.  Some of these signals include DDR response via ATM 
(Sancak et. al. 2007, Watanabe et. al. 2011).  Given that PRAS40, TOR, and p70 S6 Kinase are direct 
downstream effectors of Akt and that they are intimately related functionally, it makes sense that 
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their levels of phosphorylation would have similar patterns under infection by MPyV.  Additionally, 
the important role of mTAg in activating these pathways is directly linked to activation of Akt which 
initiates all of these downstream effects.  Moreover, it becomes increasingly apparent that the MPyV 
mutant NG59 may have retained partial functionality due to the higher levels of activation observed 
as compared to infection by mutant 808A.  Though the p-values between mutant NG59 and mutant 
808A are not statistically significant for these proteins, they may be biologically significant and could 
become statistically significant if greater than two replicates are considered.   
p27 is another example of what appears to be a biologically significant trend that is not 
calculated as statistically significant within two replicates.  Control of the cell cycle is tightly regulated 
under normal conditions.  It is interesting that during infection of MPyV RA, there is a five-fold 
reduction in phosphorylation of p27 as compared to an uninfected sample.  The virus must either 
directly or indirectly be affecting the activation state of p27 to promote cell cycle progression to S 
phase.  Data for the activation state of RSK shown in the appendix indicates that RSK is activated in 
the presence of MPyV RA and NG59.  Evidence from Larrea et. al. 2009 has shown that RSK can 
phosphorylate p27 at T198 which mislocalizes p27 from the nucleus to the cytoplasm.  Additionally, 
PI3K, which is known to be activated in the presence of PyV can contribute to mislocalization of 
p27.  This activation of p27 directly leads to increased cell motility which is related to metastatic 
activity in the context of cancer cells (Larrea et. al. 2009).   
SV40 sTAg (analogous to MPyV mTAg) has been characterized by its propensity for binding 
PP2A.  SV40 sTAg has an inhibitory effect on PP2A which results in loss of its phosphatase activity.  
There is evidence for SV40 sTAg, together with PP2A actively working to reduce p27 and its hold 
on the cell cycle (Schuchner S. and Wintersberger 1999).  This data was obtained via transfection of 
plasmids containing PyV sTAg.  Here I have established a pattern that mimics these results during 
full infection by MPyV.  MPyV RA, expressing mTAg as normal, saw the largest reduction in 
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phosphorylation of p27 as would be expected.  Furthermore, knowledge of MPyV mTAg interaction 
with PP2A to promote cellular transformation via disruption of the cell cycle indicates that the virus 
collaborates with this phosphatase to execute the effects observed on p27.  Repeated observations 
of the phosphorylation levels of p27 would be beneficial in solidifying conclusions made about the 
interaction between viral TAgs and the p27 protein.   
This study highlights the importance of studying MPyV TAgs and their effects on the cell 
independently of SV40 TAgs.  While structurally similar, evidence for TAgs from the two viruses 
seems to show that they may differ somewhat in carrying out their functions.  More work is needed 
to comprehend the complex interactions that the viruses have on cell signaling proteins that support 
efficient viral replication.  Additional data from the phospho-kinase array implicates other 
fundamental signaling pathways such as ERK/MAPK, JAK/STAT, and interactions with p53.  
Follow-up investigations with the MPyV mutant NG18 which produces a truncated and functionally 
deficient mTAg transcript and no sTAg transcript would be prudent to further elucidate the 
influence of TAgs on these processes and pathways. 
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VII. Appendix 
Figure A1: Complete Phospho-Kinase Array Data 
 
All phospho-targets represented here were produced in the same manner as the ones 
discussed previously.  These data are interesting, but have yet to be thoroughly analyzed. 
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Figure A2: Phospho-Kinase Array Membranes and Antibody Location Key 
 
 The key to the membranes from the R&D Phospho-kinase array depicts the dots and assigns 
them a specific coordinate.  Each dot then corresponds to the antibody for a particular protein as 
listed below.  Additionally, the coordinate at which a particular phosphorylation mark is assessed is 
noted.  Some proteins were repeated in the assay with different phosphorylation marks (e.g. Akt, 
p70 S6 Kinase, p53, etc.).  There are two distinct dots per protein and phosphorylation mark. 
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